Section Arrow
JAGX.NASDAQ
- Jaguar Health Inc.
Quotes are at least 15-min delayed:2026/07/17 12:50 EDT
Regular Hours
Last
 1.23
-0.105 (-7.87%)
Day High 
1.2945 
Prev. Close
1.335 
1-M High
3.07 
Volume 
237.03K 
Bid
1.21
Ask
1.25
Day Low
1.02 
Open
1.27 
1-M Low
1.2601 
Market Cap 
6.48M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.31 
20-SMA 2.51 
50-SMA 2.88 
52-W High 92.75 
52-W Low 1.2601 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-695.50/-0.04
Enterprise Value
22.46M
Balance Sheet
Book Value Per Share
-2.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.39M
Operating Revenue Per Share
2.28
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ATAIAtaiBeckley Inc7.19+0.04+0.56%-- 
IOVAIovance Biotherapeutics4.975+0.315+6.76%-- 
RXRXRecursion Pharmaceuticals2.9799-0.0401-1.33%-- 
LIMNLiminatus Pharma Inc0.125-0.0227-15.37%-- 
KLRSKalaris Therapeutics Inc5.41+0.8+17.35%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Companyfocuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.